Every two weeks, a 5-year-old with a deadly brain tumor receives CAR-T-cell therapy at Seattle Children's Hospital. With over 70 treatments, significant tumor shrinkage has been observed, prompting researchers to seek ways to replicate this success in more patients.
Initial clinical trials suggest that CAR-T-cell therapy may be effective against deadly CNS cancers in children. While larger trials are needed to confirm efficacy, researchers are optimistic about the potential of this approach and are exploring ways to optimize its effectiveness.
[
Collection
]
[
|
...
]